Pattern Bioscience utilizes single-cell microbiology to provide rapid identification and antimicrobial susceptibility testing results within hours, bypassing traditional culture methods. The company addresses the issue of antibiotic misuse in hospitals, which leads to ineffective treatments and contributes to antibiotic resistance.
Funding
$28.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
OCFounders
Product
Problem
In hospitals, a significant percentage of prescribed antibiotics are unnecessary or inappropriate, leading to ineffective treatments and contributing to the rise of antibiotic resistance. Traditional bacterial identification and antimicrobial susceptibility testing (AST) methods rely on time-consuming culture-based techniques, delaying appropriate treatment decisions.
Solution
Pattern Bioscience offers a rapid diagnostic platform that leverages single-cell microbiology to deliver definitive bacterial identification and antimicrobial susceptibility testing (ID/AST) results within hours, bypassing the need for traditional culture methods. By decoding the metabolic patterns of individual bacterial cells, the platform provides actionable information for clinicians to make informed decisions about targeted antibiotic therapy. This rapid response enables focused antibiotic treatment, improving patient outcomes and reducing the selective pressures that contribute to antibiotic resistance. The technology offers trusted phenotypic testing for all common infection sites.
Target Audience
The primary target audience includes hospital laboratories, microbiology supervisors, medical lab scientists, medical directors, pharmacists, physicians, and infection prevention specialists.
Features
- Single-cell microbiology technology for rapid bacterial identification and AST
- Direct phenotypic testing, bypassing time-consuming culture steps
- Definitive ID/AST results available within hours
- Enables focused and targeted antibiotic treatment